$4.20
0.00%
Nasdaq, Oct 26, 03:59 pm EDT. Closed.
ISIN
CA03879J1003
Symbol
ABUS

Arbutus Biopharma Corporation Stock price

$4.20
-0.66 13.58% 1M
-0.08 1.87% 6M
-0.61 12.68% YTD
-0.27 6.04% 1Y
+2.44 138.64% 3Y
+0.13 3.19% 5Y
+1.03 32.28% 10Y
-3.02 41.81% 20Y
Nasdaq, Closing price Mon, Oct 26 2026
+0.00 0.00%
ISIN
CA03879J1003
Symbol
ABUS
Industry

Is Arbutus Biopharma Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.

Key metrics

Basic
Market capitalization
$832.0m
Enterprise Value
$742.5m
Net debt
positive
Cash
$92.6m
Shares outstanding
197.6m
Valuation
P/E
5.4
P/S | estimate
4.6 | 4.5
EV/Sales | estimate
4.1 | 4.0
EV/FCF | ex SBC
negative | negative
P/B
3.2
Financial Health
Equity Ratio
80.9%
Return on Equity
-43.8%
ROCE
55.2%
ROIC
-
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$5.5m | 3.0%
SBC as % of FCF
-
SBC Growth 1Y
-33.0%
Share Count Growth 1Y
3.1%
Shareholder Yield
-3.1%
Financials
Revenue | estimate
$181.7m | $185.8m
EBITDA
$149.4m
EBIT
$149.4m
Net Income
$153.1m
Free Cash Flow | ex SBC
$-24.6m | $-30.1m
Growth
Revenue | estimate
1,078.5% | 1,219.9%
EBITDA
453.1%
EBIT
444.8%
Net Income
382.1%
Free Cash Flow
59.1%
Margin
Gross
-
EBITDA
82.2%
EBIT
82.2%
Net
84.2%
Free Cash Flow | ex SBC
-13.6% | -16.6%
More
EPS
$0.8
FCF per Share
$-0.1
Short interest
38.5%
Employees
19
Rev per Employee
$740.0k

Arbutus Biopharma Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Arbutus Biopharma Corporation forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Arbutus Biopharma Corporation forecast:

Buy
86%
Hold
14%

Financial data from Arbutus Biopharma Corporation

Jun '26
+/-
%
182 182
1,078% 1,078%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 16 16
10% 10%
9%
- Research and Development Expense 18 18
53% 53%
10%
149 149
453% 453%
82%
- Depreciation and Amortization 0.04 0.04
96% 96%
0%
EBIT (Operating Income) EBIT 149 149
445% 445%
82%
Net Profit 153 153
382% 382%
84%

In millions USD.

Don't miss a Thing! We will send you all news about Arbutus Biopharma Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arbutus Biopharma Corporation Stock News

Neutral
GlobeNewsWire
●
5 days ago
WARMINSTER, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that the Company was notified by the U.S. Food and Drug Administration (“FDA”) that the clinical hold on the Investigational New Drug (“IND”) application for AB-101 has been removed...
Neutral
GlobeNewsWire
●
26 days ago
WARMINSTER, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the final results of its tender offer (the “Offer”) to purchase for cancellation up to US$230 million in value of its common shares (the “Shares”). The Offer proceeded by way of a m...
Neutral
GlobeNewsWire
●
27 days ago
WARMINSTER, Pa., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the preliminary results of its tender offer (the “Offer”) to purchase for cancellation up to US$230 million in value of its common shares (the “Shares”). The Offer proceeded by way...
More Arbutus Biopharma Corporation News

Company Profile

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Head office Canada
CEO Ms. Androski
Employees 19
Founded 2005
Website www.arbutusbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today